Delivery Order SPE2DB22D3004-SPE2DB24FPH71
Award Date 2/14/24
Potential Completion Date 2/15/24
Potential Value $4.3K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of RINVOQ ER 45 MG TABLET in quantities of 28. The completion date for this $6,863.94 contract is January 30, 2024. Amerisourcebergen Drug Corp, a for-profit organization, is the prime contractor and will fulfill this order from its Corporate Office location in Conshohocken, Pennsylvania. This delivery order is...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide RINVOQ ER 15 MG TABLET UU 30S, a pharmaceutical product, with a ceiling value of $7,663.90. This delivery order contract has a period of performance through March 18, 2024 and was awarded on March 15, 2024. Amerisourcebergen Drug Corp is the prime contractor on this award, which is part of a larger $999,999,999.00...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for $18,046.26 to provide RINVOQ ER 30 MG TABLET UU 30S. This order is part of an indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen to deliver...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, to provide RINVOQ ER 30 MG TABLET UU 30S. The contract has a potential value of $16,973.25 and a performance period through January 29, 2024. Amerisourcebergen Drug Corporation is the prime contractor, with no set-aside designation indicated. This delivery order is issued under a larger indefinite...
- This is a $16,177.97 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of RINVOQ ER 15 MG TABLET UU 30S. The contract has an ultimate completion date of August 21, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded this contract as a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4564109799 RINVOQ ER 30 MG TABLET UU 30S. The contract has a ceiling value of $3,999.43 and a period of performance through March 29, 2024. Amerisourcebergen Drug Corp is the prime contractor and has been awarded multiple federal contracts by DLA to provide pharmaceutical products and medical supplies in...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract, valued at $7,275.16, to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of the pharmaceutical product RINVOQ ER 30 MG TABLET UU 30S. The contract has a period of performance through March 12, 2024. Amerisourcebergen Drug Corp is also the prime contractor on a separate $999,999,999.00 indefinite delivery contract (IDC) awarded by DLA, which serves as the...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $10,702.11 to Amerisourcebergen Drug Corp, a for-profit organization, to provide the pharmaceutical product RINVOQ ER 15 MG TABLET UU 30S. This order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 and a performance period through December 31, 2025, which serves as the primary contract vehicle for Amerisourcebergen Drug Corp to deliver pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $7,074.07 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of RINVOQ ER 30 MG TABLET UU 30S. This order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA Troop Support Medical, with a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary...
- The Defense Logistics Agency (DLA) has awarded a $8,241.24 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp's Corporate Office Division to provide 4564530227 RINVOQ ER 15 MG TABLET UU 30S. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that AmerisourceBergen holds with DLA Troop Support Medical to deliver a comprehensive range of pharmaceutical products and medical supplies to support the Department of Defense (DoD)...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB24FPH71Delivery Order
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide RINVOQ ER 15 MG TABLET UU 30S, a pharmaceutical product, in Conshohocken, PA. The $4,281.68 contract has a completion date of February 15, 2024 and was awarded on February 14, 2024. This delivery order is part of Amerisourcebergen Drug Corp's larger indefinite delivery contract with DLA, valued at up to $999,999,999.00 through December 31, 2025, to deliver pharmaceutical products and medical supplies to support the Department of Defense's military treatment programs and facilities worldwide. No set-aside designation was used for this contract.
Generated 5/19/24, 12:20 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.3k | 2/14/24 |